Glycom

What Glycom does

Glycom is a Danish biotechnology company founded in 2005 and headquartered in Hørsholm, Denmark, specializing in Human Milk Oligosaccharides (HMOs), the non-digestible carbohydrates that constitute the third-largest solid component of human breast milk. The company operates as an HMO product line within dsm-firmenich's Health, Nutrition & Care segment and markets its ingredients under the GLYCARE® brand. Glycom maintains one of the largest commercially available HMO portfolios, drawing from a knowledge base of over 200 identified HMO structures, and operates a fully integrated, dedicated HMO manufacturing site in Denmark for end-to-end production control. The company also supplies analytical standards for HMO purity, quality, and stability and runs an HMO Donation Program that has supported more than 100 research projects across 55 research centers globally since 2010.

Glycom's commercial offering targets two primary B2B customer segments: manufacturers of early life nutrition products (infant formula and follow-on nutrition) and producers of dietary supplements focused on gut health. HMO applications are positioned around gut, immune, cognitive, and brain health benefits across the lifespan, with regulatory approvals covering more than 165 countries. The business model is enterprise ingredient sales with quote-based pricing, customized solutions, market-ready solutions, and premix offerings, supported by expert services in application, regulatory, sensory, and scientific domains. The company sells through dsm-firmenich's global enterprise B2B channels, with direct partnership, sample, and quote request workflows.

As a subsidiary rather than a standalone listed entity, Glycom does not have separately disclosed financials, an independent capital structure, or its own public investor materials; strategic direction and resource allocation are set within dsm-firmenich's broader Health, Nutrition & Care business. Headcount is reported in the 101–250 range.

Name

Glycom

Website

https://glycom.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

Glycom is a Danish biotechnology company and dsm-firmenich subsidiary that develops and manufactures Human Milk Oligosaccharide (HMO) ingredients, supplying global manufacturers of early life nutrition products and dietary supplements across more than 165 countries under the GLYCARE® brand.

Ownership category

akta.pro rank

Product category

Nutritional Ingredients (Human Milk Oligosaccharides)

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Dairy Product Manufacturing (3115)

SIC

Biological Products, (No Disgnostic Substances) (2836), Dairy Products (2020)

akta.pro primary industry

Infant Formula & Specialized Dairy Nutrition Manufacturing (AFAKAKAJ)

akta.pro secondary industry

Special Medical Purpose Infant Formula Manufacturing (FSMP/Medical Nutrition) (AFAHAHAC)

Keywords

• Human milk oligosaccharides
• Early life nutrition
• Dietary supplement ingredients
• HMO ingredient manufacturing
• Gut health ingredients

Headquarters

HQ city

Hørsholm

HQ country

Denmark

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. HMO Ingredients B2B Sales: Sale of human milk oligosaccharide ingredients to manufacturers of early life nutrition products and dietary supplements globally. The company offers customized solutions, market-ready solutions, and premix solutions to enterprise customers.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Glycom develops, manufactures, and globally supplies Human Milk Oligosaccharides (HMOs) — non-digestible carbohydrates and the third-largest solid component of human breast milk — to B2B customers manufacturing early life nutrition products and dietary supplements. The company offers one of the largest commercially available HMO portfolios under the GLYCARE® brand, supported by a fully integrated HMO production site in Denmark and complemented by expert application, technical, regulatory, and sensory services.

Product overview

dsm-firmenich's Human Milk Oligosaccharides (HMOs) portfolio represents one of the biggest commercially available HMO portfolios with industry-leading regulatory approvals spanning over 165 countries. The offering centers on GLYCARE® HMO branded products and includes various HMO structures and combinations for applications ranging from early life nutrition to dietary supplements. The portfolio is supported by a fully integrated and dedicated HMO production site, an HMO donation program supporting research since 2010, and analytical standards for R&D. Together, the products and services form an end-to-end partner ecosystem for bringing purpose-led HMO innovations to market.

Differentiator

Problem solved

Functional benefit

Brands

• GLYCARE®: HMO brand under dsm-firmenich Health, Nutrition & Care, offering human milk oligosaccharide products for early life nutrition, gut health supplements, and related health solutions.

Products and services

• Human Milk Oligosaccharides (HMOs) Non-digestible carbohydrates and the third-largest solid component of human breast milk; dsm-firmenich offers one of the biggest portfolios of commercially available HMOs with industry-leading regulatory approvals across over 165 countries. Sold B2B to manufacturers of early life nutrition products and dietary supplements.
• GLYCARE® HMO Brand Brand name under dsm-firmenich Health, Nutrition & Care for HMO products, offering human milk oligosaccharide ingredients for early life nutrition, gut health supplements, and related health solutions.
• HMO Solutions for Early Life Nutrition Industry-leading HMO solutions supporting gut, immune, brain, and other health areas in infancy and beyond, with various HMO structures and combinations, designed for infant formula and early life nutrition manufacturers.
• HMO Solutions for Gut Health (Dietary Supplements) HMO supplements and gut health solutions for the dietary supplements market, leveraging emerging HMO research for next-generation products targeted at adult and general consumer gut health.
• HMO Analytical Standards Cutting-edge analytical standards for HMO research and development, setting benchmarks for purity, quality, and stability, enabling precise measurements for HMO researchers and manufacturers worldwide.

Quantifiable outcome

• Over 100 research projects supported across 55 research centers globally since 2010

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Research Institutions via HMO Donation ProgramcoreStrategic or Co-development Partner · 1 January 2010Since 2010, the company has supported over 100 research projects across 55 research centers globally through its HMO donation program, providing access to a library of nearly 20 different HMO structures and mixtures to advance HMO research and knowledge.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• dsm-firmenich: Direct parent company of Glycom; dsm-firmenich is a global nutrition, health, and taste & scent conglomerate that owns and commercializes the GLYCARE HMO franchise across early life nutrition, dietary supplements, and adjacent categories. Comparable as the overarching commercial and scientific platform for Glycom's HMO business.
• IFF (DuPont Nutrition & Biosciences): Large specialty ingredient platform with cultures, enzymes, and HMO-adjacent offerings for infant nutrition; comparable as a broad-line nutrition ingredients incumbent supplying the same global formula manufacturers as Glycom.
• BASF Nutrition & Health: Global chemicals and nutrition major with a meaningful human nutrition ingredient portfolio including vitamins, carotenoids, and specialty ingredients for early life nutrition; comparable as a B2B ingredient supplier to the same infant formula and supplement manufacturers.
• Kerry Group: Global taste and nutrition ingredients company supplying infant formula, functional beverages, and supplement manufacturers; comparable as a B2B nutrition ingredient supplier addressing gut-health and early life nutrition end-markets.
• Tate & Lyle: Specialty food and beverage ingredients supplier with a growing portfolio in gut health, prebiotics, and human nutrition; comparable as a B2B specialty ingredients supplier targeting the same dietary supplement and nutrition brand customers.
• ADM Nutrition: Global agriculture and nutrition major with a substantial human nutrition ingredients business serving food, beverage, and supplement manufacturers; comparable as a broad-line B2B nutrition ingredient incumbent with overlapping end-customers.
• Cargill Health Technologies: Global food and nutrition ingredients platform investing in fermentation-derived and specialty health ingredients including prebiotic and microbiome-related categories; comparable as a deep-pocketed B2B entrant into HMO-adjacent nutrition ingredients.

Direct peers

• FrieslandCampina: Global dairy cooperative with an active HMO program (Aequival) for infant nutrition; comparable because it both produces HMO ingredients and competes in early life nutrition and dairy-derived specialty nutrition markets.
• Novonesis (formerly Chr. Hansen): Microbial and enzyme-based specialty ingredients supplier with deep penetration into infant formula, dairy, and human nutrition customers; comparable as a B2B fermentation/specialty nutrition ingredient supplier serving overlapping infant nutrition manufacturers.

Emerging players

• Inbiose: Belgian biotech specialist focused on human milk oligosaccharide development and production using proprietary fermentation technology; comparable as a direct HMO innovator competing for the same B2B customers and approvals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/dsmfirmenich
• YouTubeyoutube.com/@dsm-firmenich
• Facebookfacebook.com/dsmfirmenich
• LinkedInlinkedin.com/company/glycom-a-s
• Instagraminstagram.com/dsmfirmenich

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Glycom